by Darren McCoy, FNP-BC, CPE

Portrait of Darren McCoy

Research into nonopioid pain treatments was the focus of this July 2016 commentary by Darren McCoy, FNP-BC, CPE, at Pain Consultants of East Tennessee.

News coverage at the time explored efforts to develop additional medications for pain. That research raised a broader question: How can clinicians expand treatment options while carefully considering the benefits and risks of each approach?

Evaluating Pain Treatment Options

Developing a new medication requires research into its effectiveness, safety, and appropriate use. An experimental treatment’s early promise does not establish that it will become an approved or suitable option.

The distinction between opioid and nonopioid medication also does not eliminate the need for individualized evaluation. Nonopioid medications can have side effects and may not be appropriate for every person.

Treatment decisions require consideration of the condition being treated, medical history, other medications, and goals for daily function.

Why Ongoing Evaluation Matters

A pain management plan needs regular review. Clinicians and patients can discuss whether treatment is helping, whether side effects have developed, and whether needs or goals have changed.

This commentary highlighted the importance of continued research and thoughtful reassessment. Expanding treatment options and evaluating existing care are both part of that process.

To learn more about care at PCET, contact Pain Consultants of East Tennessee or call (865) 579-0552.